Cambridge
Cambridge, GB · 1 known investors
Cambridge Nucleomics develops a single-molecule RNA counting "nanoarray" assay based on solid-state nanopore and DNA nanotechnology for diagnostic testing. The company applies its technology to RNA biology and microbiology-based diagnostics.
Founders & leadership
HR
Hendrik RungeFounder & CEO
UK
Ulrich KeyserScientific Founder
AC
Anthony CookeChairman
JY
John YeomansDirector
MZ
Max ZhuDirector